Skip to content
53

nootropic

Worth a look

Shows low returns (0.1%), but soft demand (-21.2% this quarter) keeps it on the watch list.

Market size 31Growth 14Conversion 66Competition 46Returns 100Price range 88Avg price 95Brand share 37Review moat 75Quality gap 58

Returns

Incredible0.1%

return rate — above 5% kills the launch gate

Avg price

Incredible£23.35

avg listing price — sweet spot $15–$100

Price range

Great£7.97–£94.01

cheapest to priciest tracked listing — scored on the share inside $15–$100

Review moat

Good501.17

avg incumbent reviews — the moat a new listing must climb

Conversion

Good5.9%

search→purchase rate — share of searches ending in a sale

Quality gap

Good4.4★

avg incumbent rating — lower means beatable quality

Competition

Okay57%

top-5 click share — leaders hold, buyers still browse

Brand share

Okay83%

top-5 brand share — brands hold most of the demand

Market size

Okay£143K

£143K/yr · 105K searches

Growth

Bad-21.2%

90-day search growth — must beat 0% to launch